Most people think of vaccines as being "preventive," and taken to "prevent or lessen the impact of certain infectious ...

Early data suggest personalized neoantigen vaccines activate the immune system and sustain tumor control in some patients with kidney cancer.

Researchers conducted a phase 1 trial (ClinicalTrials.gov identifier NCT02950766) at Dana-Farber Harvard Cancer Center, Boston, to evaluate a neoantigen-targeting personalized cancer vaccine in ...

A personalized neoantigen vaccine may be effective in patients with clear cell renal cell carcinoma, shared David A. Braun, ...

Researchers have harnessed the power of artificial intelligence to design a blueprint for building a vaccine that aims to ...

Additional studies in lung cancer in combination with chemoimmunotherapy in metastatic disease, 78 glioblastoma after surgery and radiation, 79 and pancreatic cancer 80 suggested that peptide and RNA ...

Advancing the battleground against cancer, this research meticulously details the development of neoantigen vaccines, a beacon of hope in personalized cancer therapy. These vaccines are custom ...

All nine patients showed a “successful anti-cancer immune response” after getting the vaccine. Hector Pertuz – stock.adobe.com. Within three weeks of receiving the vaccine, patients showed ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at ...

Advancing the battleground against cancer, this research meticulously details the development of neoantigen vaccines, a beacon of hope in personalized cancer therapy. These vaccines are custom ...